The mechanism of ROC-325 is to antagonize renal cell carcinoma (RCC) growth and survival by inhibiting ATG5/7-dependent autophagic degradation and inducing apoptosis (Carew et al., 2017). The gene discussed is ATG5; the disease is renal cell carcinoma.